跳至主要内容
临床试验/NCT00971269
NCT00971269Unknown1 期

A Pilot Study of Intersphincteric Injection of NASHA/Dx Gel for Fecal Incontinence

Uppsala University Hospital1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
1 期
入组人数
16
试验地点
1
主要终点
Change in fecal incontinence episodes

研究概览

简要总结

The study is an open, prospective, single-site study where 16 patients suffering from fecal incontinence will be included. Change in fecal incontinence episodes after intersphincteric injection of NASHA/Dx gel 4x2 ml and retreatment 4x2 ml after 4 weeks will be measured.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fecal incontinence with at least 2 episodes/week
  • Symptom duration at least one year
  • Failed attempt of conservative therapy
  • Written informed consent
  • Available for follow-up
  • Fully compliant with protocol

排除标准

  • Active inflammatory bowel disease
  • Total external sphincter defect at ultrasound and clinical examination
  • Bleeding diathesis or anticoagulant therapy
  • Rectal prolapse or intussusceptions
  • Present anal sepsis
  • Anorectal implants
  • Recent anorectal surgery (within 6 months)
  • Rectal anastomosis
  • Pregnancy, postpartum (one year) or breast feeding

结局指标

主要结局

Change in fecal incontinence episodes

时间窗: Follow up during a four week period and after 6 and 12 months

次要结局

  • Side effects related to treatment(12 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验